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"We must not wait for things to come, believing that they are decided by 
irrescindable destiny. If we want it, we must do something about it" 
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Abstract 
 
Thymic epithelial cells (TECs) are master regulators of T cell development. The 
differentiation of TECs into functionally distinct cortical (cTECs) and medullary 
(mTECs) subpopulations relies on reciprocal instructive signals from developing 
thymocytes, a bi-directional interaction known as "thymic-crosstalk". Both TEC 
subsets derive from a common bipotent progenitor and differentiate through 
compartment-specific progenitors. Albeit the cellular and molecular mechanisms 
regulating mTEC development have been partially clarified, little is known about 
the signals that control cTEC differentiation. Exploiting IL-7 reporter mice, in 
which yellow fluorescent protein (YFP) expression identifies cells that co-express 
high levels of Il7 (IL7hi/YFP+ TECs), we previously showed that IL7hi/YFP+ TECs gradually 
diminish with age in a thymocyte-dependent manner, segregate from mTECs and 
are conversely sustained when T cell development is profoundly abrogated at 
very early stages of differentiation.  
In this thesis, we study the lineage relationship between IL7hi/YFP+ TECs and 
other well-characterized TEC subtypes and the impact of distinct molecular 
interactions between thymocytes and TECs in the differentiation of the thymic 
epithelium. We demonstrate that IL7hi/YFP+ TECs emerge early during thymic 
ontogeny, define a CD205+BP1+CD40lo cTEC subset that gradually decline during 
thymic development, co-express the cortical-associated thymopoietic factors 
Ccl25, Dll4, Il7, Psmb11 and segregate from mature mTECs expressing Ctts, 
Tnfrsf11a and Aire. Furthermore, we show that the decline in IL7hi/YFP+ TECs 
induced by lympho-stromal interactions dissociates from the RANK- and LTβR-
mediated maturation of medullary epithelium, suggesting that IL7hi/YFP+ TECs do 
not represent a direct progeny of mTECs. Studies in Rag2-/- IL-7 reporter mice, 
displaying a block at the DN3 stage of T cell development, indicate that IL7hi/YFP+ 
TECs are prominently maintained during fetal and postnatal life, suggesting that 
their homeostasis is regulated by thymocyte-derived signals beyond β-selection. 
In vivo analysis of anti-CD3-treated Rag2-/- mice show that induction of DP 
thymocytes devoid of TCR expression moderately affect IL7hi/YFP+ TECs while 
fostering mTEC differentiation.	  
Together, our results indicate that IL7hi/YFP+ TECs are a determinant of the 
cortical lineage and provide evidence that the homeostasis of the cortical 
epithelium is controlled by TCR-MHC interactions between thymocytes and TECs 
occurring during thymocyte selection.	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Resumo 
	  
 
As células epiteliais do timo (TECs) são essenciais para o desenvolvimento das 
células T. A diferenciação das TECs em subpopulações corticais (cTECs) e 
medulares (mTECs), depende de sinais de maturação fornecidos pelos timócitos, 
uma interação bidirecional denominada “thymic crosstalk”. Ambas as 
subpopulações de TECs derivam de um precursor comum bipotente e 
diferenciam-se através de progenitores específicos. Enquanto os mecanismos que 
regulam o desenvolvimento das mTECs estão parcialmente clarificados, aqueles 
envolvidos na formação das cTECs não foram ainda esclarecidos. Anteriormente, 
utilizando ratinhos transgénicos que continha uma proteína repórter fluorescente 
(YFP) para detetar células com elevada expressão de Il7 (IL7hi/YFP+ TECs), foi 
demonstrado que as IL7hi/YFP+ TECs diminuem gradualmente com a idade, 
divergem das mTECs e persistem ao longo do tempo quando o desenvolvimento 
das células T é comprometido. 
No presente trabalho pretende-se explorar a relação entre IL7hi/YFP+ TECs e 
outros subtipos de TECs, assim como compreender qual o impacto "thymic-
crosstalk" no desenvolvimento do epitélio tímico. Os nossos resultados 
demonstram que as IL7hi/YFP+ TECs surgem cedo durante a ontogenia tímica, 
definem um subgrupo de CD205+BP1+CD40lo cTECs que diminuem gradualmente 
com a idade, co-expressam fatores timopoiéticos associados com o cortex, e 
divergem das mTECs maduras que expressam Ctts, Tnfrsf11a and Aire. 
Mostramos ainda que o declínio das IL7hi/YFP+ TECs, induzido por interações linfo-
estromais, dissocia-se da maturação das mTECs mediada pelos receptores RANK 
e LTβR, sugerindo que as IL7hi/YFP+ TECs não constituem uma linhagem direta das 
mTECs. Estudos com ratinhos transgénicos num fundo Rag2-/-, no qual o 
desenvolvimento das células T é bloqueado no estadio DN3, demonstram que as 
IL7hi/YFP+ TECs persistem durante o desenvolvimento fetal e pós-natal, indicando 
que a homeostasia destas células é regulada por sinais derivados dos timócitos 
que progridem para lá da seleção β. Estudos in vivo de ratinhos Rag2-/- tratados 
com o anticorpo anti-CD3 mostraram que a indução de timócitos DP desprovidos 
de TCR afetam moderadamente as IL7hi/YFP+ TECs, enquanto promovem a 
diferenciação das mTECs.  Em conclusão, os resultados apresentados indicam 
que as IL7hiTECs são determinantes da linhagem cortical, evidenciando que a 
homeostasia do epitélio cortical é controlada por interações TCR-MHC entre 
timócitos e TECs que ocorrem durante a seleção timica. 
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The Immune System 
 
The immune system has evolved to protect the organism from a universe of 
external and internal threats. The environment contains a wide range of 
pathogenic microbes and allergenic substances that challenge the host through a 
large spectrum of mechanisms. To resolve these challenges, the immune system 
uses a complex myriad of cells and molecules that respond to foreign antigens 
whilst avoiding harm the host-tissues [1]. 
Immunologic defences are divided into two main branches distinguished by 
the speed and specificity of the response. The innate immunity, an ancient 
defence mechanism, initiates an immediate response against foreign pathogens 
that is largely non-specific and does not generate immunological memory. The 
innate immune system provides the first line of defence using chemical mediators 
and physical barriers, as well as cellular components, which become activated 
during an inflammatory response. The adaptive immunity, unlike the innate 
immune response, relies on the clonal expansion of antigen-specific B and T 
lymphocytes. A hallmark of this response is the ability to induce immunological 
memory, with the formation of long-lived cells that persist in a quiescent state 
and ensure a rapid response upon re-exposure to the same antigen. Nonetheless, 
despite the differences between innate and adaptive immune responses, the 
interplay between elements of both systems provides an effective defensive 
network [2].  
All the components of the immune system are generated from a pool of 
multipotent hematopoietic stem cells (HSC), in a highly orchestrated process 
termed hematopoiesis. This event begins early during embryogenesis and has the 
fetal liver and bone marrow as the major niches of hematopoiesis. After 
expansion, some HSC migrates into distinct anatomical locations, such as the 
thymus, in order to commit and develop into a specific hematopoietic lineage [3]. 
Despite the benefits, a misguided immune response can not only compromise 
the ability of our system to respond against pathogens but also the 
immunological tolerogenicity to self-antigens, increasing the chance of 
developing allergic or autoimmune syndromes. Thus, the instruction and 
maintenance of an immunological self-tolerant state is ensured by the 
coordinated action of central and peripheral mechanisms [4]. Central tolerance 
plays an important role purging auto-reactive cells from the newly developing 
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lymphocyte repertoire (disclosed later in this thesis). However, this mechanism is 
not perfect and allows the escape of some auto-reactive lymphocytes into the 
periphery [5]. Therefore, peripheral tolerance provides a downstream control 
mechanism that include anergy and clonal deletion of auto-reactive lymphocytes 
as well their suppression by a specialized subset of T cells, the regulatory T cells 
(Treg) [5]. 
 
The Thymus as a T Lymphocyte School 
 
The word “thymus” is thought to derive from a Greek word θυµοЅ, meaning 
“heart” or “soul”. The ancient Greeks were the first to originally describe this 
organ and they believe it was the place of the “soul” because its anatomical 
position lies above the heart. Along centuries the thymus was considered an 
enigmatic organ, surrounded by many questions regarding to its function. 
Although during the 1950s, the thymus was recognized as a lymphocyte 
producing-organ, the immunologists were sceptical about a possible 
immunological function of this organ and it was considered as a redundant 
“lymphocyte graveyard” [6]. However, the importance of the thymus was only 
documented in 1961 by Jacques Miller's studies on virus induced-leukaemia in 
young thymectomyzed mice. His observations lead to the recognition of the 
thymus as a non-redundant specialized organ of the immune system with a 
crucial role in the development of T cells [6,7]. 
Anatomically, the thymus is a bilobated organ that is located in the superior 
anterior mediastinum. Histologically, each lobe is composed by two distinct 
regions that includes an outer cortex and inner medulla [8]. The unique capacity 
of this organ to support T cell development, or thymopoiesis, relies on an 
organized tridimensional network of thymic stromal cells that provides the 
essential molecular cues for maturation, expansion and selection of T cell 
precursors, also known as thymocytes. The thymic stroma is heterogeneous and 
is composed of dendritic cells, macrophages, fibroblasts, endothelial cells and 
thymic epithelial cells (TECs) [9]. TECs are the major constituent of the thymic 
stroma and are categorized into cortical (cTECs) and medullary (mTECs), 
according to their spatial location, morphology and functional proprieties. These 
subsets are responsible for supporting distinct stages of T cell development. 
Chapter I | Introduction 
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Whereas cTECs support early stages of T cell development, mTECs guide later 
stages of T cell development [10–12]. 
Throughout life, the thymus contributes with a permanent output of naive T 
cells, reaching a peak of activity during the early adulthood in mice [13]. 
Nevertheless, the size and function of this organ starts progressively 
degenerating with age, concomitantly with the disruption of the normal cortical 
and medullary thymic architecture. Consequently, the capacity of the thymus to 
support thymopoiesis becomes gradually compromised, thereby contributing to a 
reduced immune surveillance. This phenomenon is known as thymic involution 
and is thought to be an important contributor for the immunosenescence-
associated problems, by leading to an indirect increase in the susceptibility to 
infectious diseases, neoplastic and autoimmune disorders during elderly [14,15]. 
 
Thymic Organogenesis 
 
Thymic organogenesis is a tightly coordinated process, that comprises a series 
of morphogenetic and differentiation events and relies on the interaction of cells 
from all three embryonic germ layers (endoderm-derived epithelium, ectoderm-
derived neural crest (NC) mesenchyme, mesoderm-derived hematopoietic cells) 
[16]. 
The murine thymus develops from the ventral region of the third pharyngeal 
pouches of the foregut endodermal tube. Although the signals that initiate the 
thymic development take place around embryonic day 9.5 of gestation (E9.5), the 
first morphological signs are only visible at E10.5 with the budding and 
outgrowth of the thymic anlage [16]. Between E11.5-E12, the first wave of 
lymphoid progenitor cells colonizes the thymic anlage, entering through the 
mesenchymal layer in response to chemoattractive factors [17]. The following 
stages of thymic organogenesis require detachment, patterning and 
differentiation of different thymic stromal cell subsets and migration of the 
thymus into its final anatomical position (Figure 1) [18,19].  
During embryogenesis, the thymic primordium becomes delimited by a NC-
derived mesenchyme, which contributes to the formation of the capsule and the 
thymic blood vasculature [8,20]. In addition, the surrounding NC mesenchymal 
cells influence the proliferation and homeostasis of TECs through the production 
of fibroblast growth factors (FGF), such as FGF7 and FGF10 [18,21,22], as well as 
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retinoic acid (RA) and insulin-like growth factor (IGF)-1 and -2 [23,24]. In addition, 
whereas the mesenchyme does not appear to be required for the initial thymic 
fate induction [8,25], the positioning of the organ and its separation from the 
pharynx relies on signals provided by NC-derived mesenchyme [26].  
 
 
In the past, there were some conflicting interpretations about the precise 
contribution of the endodermal and ectodermal layers for the development of the 
thymic epithelium. Two different hypotheses had been proposed, one arguing in 
favour of a dual origin with participation of both endoderm and ectoderm layers, 
whereas the other one defends an exclusively endodermal origin for thymic 
epithelium. However, it is currently accepted that TECs originate solely from a 
unique germ layer, the endoderm [8,18,27]. 
The early organogenesis of the thymus is intimately connected with the 
formation of the parathyroid gland, which arises from the dorsal part of the third 
pharyngeal pouch, developing as a shared structure. Differentiation into 
parathyroid and thymus specific domains is driven by the spatial-specific 
expression of two transcription factors Glial cells missing homolog 2 (Gcm2) and 
Forkhead box N1 (Foxn1), respectively [28]. Foxn1, a gene encoded by the nude 
locus, exhibits a vital role during thymic organogenesis by governing the 
 
Figure 1 - A schematic overview of thymic organogenesis: The thymic anlage is formed from an outgrowth of the 3rd 
pharyngeal pouch. The surrounding NC-derived mesenchyme influences the thymic anlage growth and separation off 
the pharynx (Adapted from [18]) 
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differentiation of TECs [29,30] in a cell-autonomous manner [31]. The expression 
of Foxn1 is first detectable in the ventral region of the third pharyngeal pouches 
as early as E11 [28], although the molecular mechanisms that initiate and control 
Foxn1 gene expression remain elusive. Some evidence suggests that Bone 
morphogenetic protein 4 (Bmp4) and Wingless-related MMTV integration (Wnt) 
signals might regulate Foxn1 expression in TECs in vitro [32,33], even though the 
role of these proteins in vivo remains to be proven. 
 
Thymic Epithelial Cells - The Educators of Thymopoiesis 
 
The partitioning of TECs into two specialized subpopulations, cTECs and 
mTECs, is essential to guide distinct stages of thymopoiesis. In recent years, TECs 
have been extensively studied with the purpose of gaining a better understanding 
about the precursor-progeny relationship and the cellular and molecular 
mechanisms behind the establishment of a functionally competent TEC 
microenvironment.  
Despite the high level of heterogeneity observed among the thymic epithelium, 
the two TECs subtypes can be identified based on the phenotypically expression 
of specific markers [34,35]. Whereas cTECs are defined by the expression of 
cytokeratin-8 and -18 (K8+ and K18+), Ly51+ (also known as BP1) and CD205+ (also 
known as DEC-205) [34–36], mTECs are commonly associated with the expression 
of cytokeratin-5 and -14 (K5+ and K14+), CD80+, mouse thymic stroma 10 
(MTS10+), ERTR5+,  the tight junction components claudin-3 and -4 (Cld3+ and 
Cld4+) and the ability to bind lectin Ulex europaeus agglutinin 1 (UEA1+) (Figure 2) 
[34,35,37]. Yet, both TEC lineages share common markers such as, the 
expression of Foxn1, Epithelial Cell Adhesion Molecule (EpCAM) and the Major 
Histocompatibility Complex Class II (MHCII) [35]. As aforementioned, TECs can 
diverge, not only in their phenotypic traits and spatial location but also in their 
functional properties to promote distinct stages of T cell development. cTECs 
mediate early stages of T cell development by providing an array of thymopoietic 
factors, including CCL25, IL-7, DLL4, β5t and TSSP, which are involved in the 
attraction, commitment, expansion and positive selection of immature 
thymocytes [12,34,35]. In contrast, mTECs are critical to regulate later stages of 
thymopoiesis, particularly negative selection, through the expression of Aire-
dependent and -independent tissue-restricted self-antigens (TRA) [38,39]. 
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The concept that both TEC lineages arise from a common bipotent progenitor 
came with the identification of a particular TEC population co-expressing both 
cortical and medullary markers, namely K5+K8+ [40]. During fetal development, 
K5+K8+ TECs are widely predominant within the thymic epithelium, whereas in 
adulthood, this population represents a minor subpopulation located close to the 
cortico-medullary junction [40,41], emphasizing the idea of a common progenitor 
pool for K5+K8- mTECs and K5-K8+ cTECs. In line with the previous observations, a 
subpopulation of embryonic TECs was identified based on the reactivity to the 
monoclonal antibody MTS24 [42,43]. MTS24+ TECs, which also co-express K5+K8+, 
in contrast to MTS24- TECs, were shown to have the ability to generate a fully 
competent thymic microenvironment, compartmentalized into cortex and medulla 
[42,43]. In addition, MTS24+ TECs also were shown to have the capacity to 
support thymopoiesis when transplanted into the kidney capsule of nude mice, 
suggesting that MTS24+ TECs represent a putative TEC progenitor [42]. Yet, a 
subsequent study showed that MTS24- TECs also had the potential to generate a 
functional thymus, depending on the embryonic stage [44]. Whilst the evidence 
for the existence of a bipotent progenitor have been ascertained [45,46], the 
paucity of specific markers has significantly hampered the identification and 
localization of these cells in the embryonic and postnatal thymus. 
The current model for TEC development suggests that cTEC and mTEC 
lineages originate from a bipotent precursor and develop through compartment-
intermediate progenitors [10,12]. The first key evidence supporting this idea was 
based on the formation of multiple small clusters of mTECs derived from a single 
progenitor distinguished on the basis of different MHCII haplotypes in chimeric 
thymi [47]. Along this line, cTECs and mTECs committed progenitors have been 
identified during early ontogeny (E12). While mTEC progenitors are defined on 
the basis of the expression of tight junction components Cld3 and Cld4 [48], 
committed cTEC progenitors are established accordingly with the differential 
expression of CD205 and CD40 [49]. Moreover, the co-expression of a cTEC 
specific proteosomal subunit β5t along with CD205 was also associated with 
committed cTEC progenitors [50]. By E12, β5t+ TECs tend to be clustered in the 
ventral and outer region of the thymic epithelium, in a distinct anatomical 
location from those containing mTEC progenitors expressing Cld3/4+ [48,50]. 
Thus, one can envisage the existence of landmarked spatial niches for 
cTEC/mTEC progenitors determined early during thymic organogenesis. 
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TEC differentiation can be temporally divided in two distinct phases, which 
occurs through a thymocyte-independent and -dependent mechanism [41]. The 
compartmentalization of distinct TEC microenvironments, particularly the 
expansion of thymic medullary regions beyond E15, is not a cell-autonomous 
process and depends on thymocyte-derived signals, a symbiotic relationship 
named "TEC-Thymocyte Crosstalk" [51]. In adult mice with a profound arrest in 
early T cell development, at the DN1-DN2 stage (Rag2-/-Il2rg-/- mice; human CD3ε 
trangenic mice [Tge26] and Ikaros-/- mice), the thymic architecture is severely 
compromised, with little organization and lack of epithelial maturation 
[35,41,52]. Phenotypically, the thymus from these immunodeficient mice 
resemble a fetal thymus at E12-E14, with an abundance of TECs co-expressing 
K5+K8+ [41], suggesting that in the absence of developing thymocytes, TECs 
progenitors might be arrested in an immature stage. Still, the initial patterning of 
TECs seems to be a thymocyte-independent process [41,53], occurring 
presumably either in a cell-autonomous fashion or through interaction with non-
hematopoietic cells during early embryonic development. Nevertheless, the 
ablation of perithymic mesenchyme from a fetal thymus during the E12 does not 
preclude the differentiation into cTEC and mTEC lineages [21,36], suggesting that 
beyond E12, the compartmentalization of TECs does not require sustained 
interactions with mesenchyme. 
cTECs 
CD205
+
 
Ly51
+
 
K8
+
 
mTECs 
MTS10
+
 
UEA1
+
 
CD80
+
 
Aire
+
 
Maturation 
 
Figure 2 - A model for TEC differentiation: A common bipotent thymic epithelial progenitor cell (TEPC) has the 
potential to generate both cortical thymic epithelial cells (cTECs) and medullary TEC (mTECs), through compartment-
specific intermediate progenitors, cortical TEC progenitor (cTEPC) and medullary TEC progenitor (mTEPC), respectively 
(Adapted from [22]). 
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How does the TEC Microenvironment Instruct T Cell 
Development? 
 
While most hematopoietic lineages differentiate within the bone marrow (BM), 
the generation of a diverse and self-restricted repertoire of T lymphocytes 
requires specialized niches exclusively found in the thymus. During their 
migration throughout distinct regions of the thymic microenvironment, 
developing thymocytes undergo a sequence of differentiation, proliferation and 
maturation events (Figure 3). In fact, thymopoiesis is a tightly regulated 
phenomenon during which several checkpoints purge the production of T cells 
bearing non-functional or auto-reactive T cell receptors (TCRs) [11,54,55]. As a 
result, only 1-3% of thymocytes are able to survive and migrate into the 
peripheral secondary lymphoid organs [54]. 
The earliest thymic progenitors that colonize the thymus display a limited self-
renewal capacity. Therefore, in order to sustain T cell production, a continual 
input of BM progenitors is required [11]. Nevertheless, two recent reports 
demonstrated that, under particular conditions, neonatal thymi harbour 
thymocytes with a self-renewal capacity that are able to reconstitute the 
peripheral T-cell pool in the absence of intrathymic competition [56,57]. The 
entry of BM progenitors into the thymus does not seem to be a continuous 
process, but rather a temporally regulated event that is suggested to occur in 
discrete waves [58]. The initial seeding of hematopoietic precursors occurs prior 
to the vascularisation of the thymic primordium, through interaction with the 
surrounding mesenchymal layer [8,17]. However, in the postnatal thymus, once 
the vasculature is well developed, T cell progenitors enter across blood vessels 
located nearby the cortico-medullary junction (CMJ) [17,54,55]. The capacity of 
hematopoietic progenitors to migrate into the thymus is mediated by a 
chemotactic gradient, established by the expression of CC-chemokine ligand 21 
(Ccl21), Ccl25 and CXC-chemokine ligand 12 (Cxcl12) within the thymus and the 
correspondent interaction with their receptors CC-chemokine receptor 7 (Ccr7), 
Ccr9 and CXC-chemokine receptor 4 (Cxcr4) expressed by hematopoietic 
progenitor cells. In addition, the expression of adhesion molecules by the thymic 
endothelium, such as P-selectin, also facilitates the colonization process 
[54,55,59]. 
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Within the thymus, the earliest thymic seeding progenitors are uncommitted 
cells that retain both myeloid, NK, B and T cell lineage potential [60]. In order to 
be instructed into the T cell lineage, these cells undergo a developmental 
pathway that comprises different stages of maturation prior to the expression of 
CD4 or CD8. The most immature thymocytes are named double-negative (DN), 
due to the lack of expression of CD4 and CD8. While they migrate from the 
cortico-medullary region into the subcapsular zone, DN thymocytes sequentially 
progress across four distinct sub-stages, from DN1 to DN4, which can be 
monitored on the basis of the expression of CD25 and CD44. The migration of 
DN thymocytes occurs under the influence of a chemokine gradient, in particular 
to Cxcl12, Ccl19 and Ccl21. Moreover, during their migration to the subcapsular 
zone, the stromal production of stem cell factor (SCF), also known as Kit ligand, 
and Interleukin-7 (IL-7), are essential to support the survival and proliferation of 
these developing DN thymocytes [11,54,55]. 
The irreversible commitment towards the T cell lineage takes place at DN3 
stage and is promoted by the Notch-signalling pathway, via Dll4-Notch1 
interaction [61,62]. Simultaneously, the recombination activating gene (RAG) 
enzymes promote the rearrangement of the TCRγ, TCRδ and TCRβ locus. The 
productive rearrangement, assembly and signalling through the γδ-TCR allow the 
differentiation of DN3 thymocytes towards γδ T cell lineage [59]. With regard to 
αβ T cell differentiation, rearranged TCRβ chain assembles with an invariant pre-
TCRα chain and CD3 signalling molecules on the cell surface, to form the pre-TCR 
complex. Nevertheless, only thymocytes bearing a functional pre-TCR are allowed 
to further develop into double positive (DP) thymocytes (CD4+CD8+), a process 
known as β-selection. After passing β-selection, thymocytes initiate the TCRα 
locus rearrangement, which leads to the expression of a fully assembled αβ-TCR 
[11,54,55] and progress through a transient state as immature CD8 single 
positive (ISP) thymocytes (Figure 3) [11]. Subsequently, the newly generated DP 
thymocytes are screened for the ability of their TCR to recognize self-peptide-
MHC complexes (pMHC) with low avidity, a process known as positive selection 
[63]. Only positively selected thymocytes receive signals to survive, which allow 
them to differentiate further into CD4 or CD8 single positive (SP) thymocytes. 
cTECs are the master regulators of positive selection due to the generation of 
MHC-bound peptides presented through distinct pathways, which are mediated 
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by the expression of cortex-specific proteosome subunit β5t, thymus-specific 
serine protease (TSSP) and Cathepsin L [64–66]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Upon positive selection, thymocytes migrate to the medullary compartment in 
response to Ccr7-mediated chemotactic signals, namely Ccl19 and Ccl21, 
expressed by mTECs (Figure 3) [67]. Once within the medulla, SP thymocytes 
bearing auto-reactive TCRs against self-antigens are deleted, an essential event 
essential for the establishment of central tolerance [68]. This process is termed 
negative selection, and together with positive selection, corresponds to the most 
important checkpoints that fine-tune T cell development. Due to its unique 
property, mTECs are capable of expressing an array of tissue-restricted antigens 
(TRA) [69], a process termed promiscuous gene expression (PGE), which are 
	  
Figure 3 - A schematic overview of thymopoiesis: Once within the thymus, the hematopoietic progenitors undergo a 
differentiation pathway passing through distinct niches and checkpoints until they complete their maturation as SP 
thymocytes. However, T cell development is not a cell-autonomous process and relies on essential molecules that are 
provided by TECs (Adapted from [11]) 
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partially dependent on the transcription factor AIRE [38]. In addition, thymic 
dendritic cells (DCs) also regulate negative selection ably cross-presenting several 
self-peptides to developing SP thymocytes [70]. Thus, the interplay between 
mTECs and DCs during negative selection contributes to shape a self-tolerant T-
cell repertoire. 
SP thymocytes spend almost one week in the medullary compartment before 
egressing from the thymus. This process is regulated by the sphingosine-1-
phosphate receptor 1 (S1P
1
), a G-protein coupled receptor (GPCR) expressed on SP 
thymocytes [71]. Sphingosine-1-phosphate (S1P), the physiological ligand of S1P
1
, 
is produced by pericytes, a NC-derived population positioned nearby the CMJ. S1P 
is found in higher concentration in the circulation, which allows the establishment 
of a chemotactic gradient that regulates the egress of mature T lymphocytes from 
the thymus into the circulation [54,55]. Furthermore, it seems that the 
Ccr7/Ccl19 axis also contributes to thymocyte export at least in newborn mice 
[72], suggesting perhaps a coordinated timely regulation between Ccl19- and 
S1P-mediated emigration along development. 
 
Interleukin-7: A Critical Thymopoietic Cytokine 
 
Interleukin-7, previously known as "lymhopoietin 1" and "pre-B cell factor", was 
first discovered in 1988 as a pre-B cell growth factor [73]. Subsequently, IL-7 was 
recognized as a non-redundant and multi-faceted cytokine indispensable for B 
cell and T cell immunity [74]. IL-7 is not only an important growth factor to T cell 
precursors during thymopoiesis, but is also required for the homeostasis of naive 
and memory T cells in peripheral lymphoid organs [75,76]. Moreover, IL-7 is 
essential to lymph node (LN) and Peyer's patches (PP) development, promoting 
the survival and proliferation of lymphoid tissue inducer (Lti) cells [77].  
The pleiotropic effects of IL-7 are mediated via its receptor, IL-7 receptor (IL-
7R) [78]. The IL-7R is a heterodimeric complex composed of IL-7 receptor alpha 
(IL7-Rα) chain (also known as CD127) and the common cytokine receptor γ-chain 
(γ
c
), also shared by other cytokines of the γ
c
 family (IL-2, IL-4, IL-9, IL-15, IL-21) 
[78,79]. IL-7-derived signals are transduced through multiple signalling pathways, 
which include the phosphatidylinositol 3-kinase (PI3K), Janus kinase and signal 
transducer and activator of transcription pathway (Jak and STAT) and Src family 
tyrosine kinases [76]. Interestingly, there are some evidence suggesting that IL-7 
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signalling is an evolutionarily conserved pathway in lower and higher vertebrates 
[80]. Mutations in the γ
c
, IL7-Rα chains and in components associated with IL-7 
signalling pathway result in Severe Combined Immunodeficiency (SCID) [79,81], a 
syndrome characterized by a profound impairment in B and T cell development. 
Under steady-state conditions, IL-7 appears to be constitutively produced and 
its bioavailability limits the size of the lymphocyte pool. Nonetheless, the 
responsiveness to IL-7 is tightly controlled by the differential expression of IL7-Rα 
[82]. During thymopoiesis, IL7-Rα is expressed at the DN stage, particularly by 
DN2 and DN3 thymocytes, absent at the DP stage and re-expressed at SP stage 
[78,82]. Along these stages of T cell development, IL-7 acts as a survival factor 
balancing pro- and anti-apoptotic B cell lymphoma 2 (Bcl-2) family members 
[76,78,81]. Yet, despite its role as a pro-survival factor, IL-7 tends influences the 
T cell lineage differentiation. IL-7 signalling commits DP thymocytes into the CD8 
lineage by inducing the expression of the transcription factor Runx3 [83]. 
Moreover, γδ T-cell development relies on IL-7 signals, which regulate the 
rearrangement of the γ-chain locus by permitting the chromatin accessibility to 
the RAG enzymes [84]. Such dependency is well documented in IL7-/- and IL-7Rα-/- 
mice [85,86], in which γδ T cells are absent. 
Several reports have shown the expression of IL-7 in multiple lymphoid tissues, 
which include the thymus, bone marrow, lymph nodes, spleen, fetal and adult 
liver and intestinal epithelium [76,87]. Interestingly, very low levels of IL-7 have 
been detected in adult, which support the idea that under normal conditions the 
bioavailability of IL-7 is limited in the body [88]. Despite the knowledge about its 
biological effects, the identity of IL-7 producing cells, the anatomical niches in 
which IL-7 is active, and the mechanisms that regulate its expression remain 
largely unknown. 
The lack of experimental tools to monitor cells expressing IL-7 has hampered 
our comprehension about how IL-7 is regulated in vivo. Recently, four 
independent studies provide new insights into this issue by generating different 
bacterial artificial chromosome (BAC) transgenic mice that monitor IL-7 
expression in vivo [87]. In one of these studies from our laboratory, the IL-7 
reporter activity indicated the thymus as the main source of IL-7 and identified 
TECs as bona fide IL-7-producing cells [89]. IL-7 expressing TECs (hereafter 
referred as IL7hi/YFP+ TECs) emerge early during fetal thymic organogenesis and 
gradually decay throughout post-natal life [89,90]. Furthermore, although IL7hi/YFP+ 
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TECs display a widespread distribution in the fetal thymus, they are 
predominantly located at the CMJ in the adult thymus [89,90]. One can envisage a 
correlation between the strategically distribution of IL7hi/YFP+ TECs close the CMJ 
with the requirement of IL-7 signalling for early and post-selected thymocyte 
development. 
Nowadays, it is recognized that IL-7 expression by TECs occurs in a Foxn1-
independent fashion albeit it remains undetermined whether its expression 
initiates in a cell autonomous manner or is controlled by an exogenous signal 
[91]. In addition, the same report has also suggested that signals delivered by 
developing thymocytes regulate the IL-7 expression during ontogeny [91]. In this 
regard, in alymphoid Rag2-/-Il2rg-/- mice, which display a profound block in early 
stages of thymopoiesis, the frequency of IL7hi/YFP+ TECs is significantly augmented 
when compared with age-matched immunocompetent mice [90]. However, upon 
reconstitution with bone marrow precursors from either TCRα-/- or WT mice, the 
frequency of IL7hi/YFP+ TECs is reduced, mirroring a similar phenotype observed in 
immunocompetent mice [90]. Such evidence unveils the existence of a feedback 
mechanism in which TEC-thymocyte crosstalk curtails the expression of IL-7. Yet, 
the biological significance and the molecular events underlying this feedback 
mechanism remain far from disclosed. 
 
TEC-Thymocyte Crosstalk Governs the Epithelial 
Development 
 
As mentioned above, the establishment of distinct cortical and medullary 
microenvironments is not a cell-autonomous process and is influenced by 
thymocyte-derived signals [51]. In recent years, although the cellular and 
molecular mechanisms that underlie the TEC-thymocyte crosstalk have been 
partially deciphered, the detailed nature of this bidirectional communication 
continues largely unclear. 
Initial studies involving the characterization of mice deficient in signalling 
components of both canonical and non-canonical nuclear factor kappa B (NF-κB) 
pathway have contributed to elucidate the molecular basis behind mTEC 
development. Abrogation of downstream NF-κB-associated effectors NF-κB-
inducing kinase (NIK), Tumor necrosis factor receptor-associated factor 6 (TRAF6) 
and the transcription factor Avian reticuloendotheliosis viral (v-rel) oncogene 
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related B (RelB), caused a disorganized mTEC architecture, concomitantly with a 
marked reduction in Aire+ mTECs and consequent manifestations of 
autoimmunity [92–94]. Research over the last years has recognized the tumour 
necrosis factor receptors super family (TNFSF) members as key activators of NF-
kB signalling during mTEC development [37]. Lymphotoxin β receptor (LTβR), 
which plays a pivotal role in the organogenesis of most secondary lymphoid 
tissues, was the first TNFR member described to be involved in mTEC 
differentiation [95]. LTβR-mediated signals induce a diverse array of cellular 
processes that, albeit contributing to the development and proper organization of 
mTEC architecture, also guarantee an efficient negative selection process by 
regulating the expression of Aire-independent TRA and chemokine genes in 
mTECs [39,96]. Additional studies have described the individual and cooperative 
action of two other TNFSF members, receptor activator of NF-kB (RANK) and 
CD40, in the homeostasis of thymic medulla (Figure 4) [97,98].  
RANK is a multifaceted receptor that regulate different physiological processes 
[99]. In the thymus, RANK-mediated signals enhance the growth and optimal 
development of mTECs, including Aire-expressing cells [100]. In fact, from all 
TNFSF members, RANK appears to have the strongest impact on the medullary 
epithelium. Compared with the lack of LTβR or CD40-signalling pathways, RANK-
deficient mice exhibit the most severe phenotype characterized by a marked 
reduction in mTEC cellularity, particularly Aire+ mTECs, and impaired central 
tolerance [97,98,100]. Different cellular populations appear to express RANK 
ligand (RANKL), the physiological ligand of RANK, within discrete developmental 
windows. While CD4+CD3- LTi and Vγ5+ γδ T cells are the major source of RANKL at 
early phases of embryogenesis [101,102], RANKL is predominantly expressed by 
positively selected thymocytes during post-natal life [100]. Additionally, several 
studies have pointed to a participation of CD40-CD40L axis in the formation of 
thymic medulla after birth, simultaneously with the expression of CD40L by CD4+ 
SP thymocytes [97,103].  
Despite their individual contributions, the establishment of a mature and 
functional medullary microenvironment relies on a stepwise interplay between 
LTβR, RANK and CD40. A recent report point to a synergistic interaction between 
LTβR and RANK at early stages, during which LTβR-signals enhances RANK 
expression on mTEC precursors, thereby making TECs more responsive to RANKL 
[98]. Nevertheless, this cooperation appears only to occur during early stages of 
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organogenesis, being then substituted during post-natal life by a collaborative 
action between RANK and CD40-mediated signals [97]. Moreover, an efficient 
delivery of RANKL and CD40L is likely to occur in the context of physical 
interactions between auto-reactive CD4+ SP thymocytes and mTECs displaying the 
cognate self-antigen-MHCII complexes [104]. 
 
 
 
Although the cellular and molecular mediators that control mTEC maturation 
are partially understood, the underlying basis that regulates cTEC differentiation 
remain largely unanswered [35]. Unlike the medullary lineage, the paucity of cell 
surface markers has hampered the advances to map the developmental 
progression of cTECs. Only recently, a model for developmental checkpoints 
during cTEC differentiation has been proposed on the basis of the differential 
expression of CD205, CD40 and MHCII markers [49]. This model has proposed a 
	  
Figure 4 - A model of TEC-thymocyte crosstalk and its impact in the formation of distinct microenvironments: 
TECs derive from a bipotent precursor and develop through intermediate TEC-committed progenitors in distinct 
anatomical niches. While the initial development of TECs occur in the absence of thymocytes, its progression through 
different stages of development relies on thymocyte-derived signals (Adapted from [33]) 
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stage-specific requirement of DN thymocyte-derived signals for the proper 
development of a cortical microenvironment [49]. However, the precise nature of 
such signals and how DN thymocytes shape cTEC maturation remains largely 
unknown.  
 
Aims 
 
The thymic epithelial microenvironment undergoes a series of morphological 
and architectural modifications throughout development, which are accompanied 
by a prominent reduction in the number of TECs, particularly in cTECs [105,106]. 
Interestingly, it has been demonstrated that cTECs have the potential to 
rejuvenate the cortical compartment upon thymic injury [107]. Yet, the cellular 
and molecular basis that governs the development and maintenance of the 
cortical microenvironment remain open questions. 
In this thesis, we aim at defining novel checkpoints in the differentiation of the 
thymic cortical epithelium. Using state-of-the-art research mouse models (IL-7 
reporter mice in immunocompetent and genetically altered background), together 
with in vitro thymic organotypic cultures and in vivo functional assays, we study 
(1) the lineage relationship between IL7hi/YFP+ TECs and other well-characterized 
TEC subtypes and (2) the impact of distinct molecular interactions between 
thymocytes and TECs in the control of the homeostasis of the cortical epithelium. 
The development of approaches to promote the functional rejuvenation of the 
thymus has been one of the biggest challenges in clinical immunology. 
Comprehending the mechanisms behind TEC development will aid in the 
elaboration of tailor-made therapeutic strategies aimed at repairing and 
improving thymic functioning in different pathophysiological conditions, 
including aged-associated thymic involution, immunodeficiencies and infection. 
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Mice	  
 
These studies used transgenic mice (B6.Cg-Tg(Il7-EYFP)5Pas) carrying a 
bacterial artificial chromosome (BAC) encoding YFP under the control of the Il7 
promoter (Figure 5), inserted by homologous recombination downstream of the 
ATG start codon located at the end of the exon 1 of Il7 locus. In these mice, the 
expression of YFP is purportedly controlled by the same molecular mechanism 
that drives the expression of endogenous Il7. IL-7 reporter mice were 
backcrossed onto C57BL/6 background wild type (WT), Rag2-/- mice [108] and 
Marilyn Rag2-/- mice [109] (kindly provided by Jocelyne Demengeot, Instituto 
Gulbenkian de Ciência, PT)  for more than 9 generations. 
 
Figure 5 – BAC sequence scheme comprising Il7 gene, its promoter and YFP insertion in the gene. 
 
 
For fetal studies, the day of the vaginal plug detection was designated 
embryonic day E0.5.  
Mice were housed under specific pathogen-free conditions and all animal 
experiments were conducted accordingly to the guidelines of the Portuguese 
National Authority for Animal Health (DGV) and European Union directive 
2010/63/EU by FELASA-accredited researchers.  
 
Genotyping	  
 
In the adopted breeding scheme, transgenic mice were crossed with immuno-
competent and Rag2-/- C57BL/6 mice, resulting in a progeny of both transgenic 
and WT littermates. Tails were digested in buffer (100 mM Tris pH 8.5; 5 mM 
EDTA; 0.2% SDS; 200 mM NaCl) with 0.4 mg/ml proteinase K (Eurobio) and the 
DNA was isolated using a standard mouse tail DNA isolation protocol. Transgenic 
mice were distinguished by standard PCR, using specific primers for the Il7-YFP 
junction sequence (Forward: 5’ tacacccacctcccgcagaccatggtgagcaagggcgag-
gagctgttc 3’; Reverse: 5’ gcaccagagagcagcgcttaccatttacttgtacagctcgtccatgcc 3’). 
PCR reaction comprised 5 minutes at 95ºC for initial denaturation of DNA, and 35 
cycles of 30 seconds at 95ºC and 1 minute at 72ºC for annealing and amplifica-
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tion, followed by a final step of 5’ at 72ºC for extension. For Rag2-/- genotype, a 
set of three primers was used to discriminate WT and KO alleles (Forward: 5’ 
gggaggacactcacttgccagta 3’; Reverse: 5’ agtcaggagtctccatctcactga 3’ and neo-
Forward: 5’ cggccggagaacctgcgtgcaa 3’). PCR reaction comprised 4 minutes at 
94ºC for initial denaturation of DNA, 35 cycles of 20 seconds at 94ºC, 30 seconds 
at 72ºC and 30 seconds at 74ºC, followed by an additional final step of 5 minutes 
at 74ºC for extension. 
 
Isolation of Thymic Stromal Cells	  
 
Thymic lobes were dissected at indicated time points (for early developmental 
stages, by micro-dissection) and stromal cells were isolated as previously 
described [110]. Thymic fragments were digested for 30 minutes at 37ºC in 
trypsin (Sigma) supplemented with 1% collagenase (Sigma) and 0,02% DNaseI 
(Roche). Fragments were mechanically disrupted by ressuspension every 5 
minutes with a syringe to obtain cell suspensions. For later time points (adult 
stages), thymic stromal cells were enriched by an additional selection procedure 
that depletes hemotopoietic cells using MACS CD45 MicroBeads (Miltenyi Biotec) 
and autoMACS separation columns according to the manufacturer’s instructions. 
Cell numbers were calculated using counting chamber (Hycor Biomedical). 
 
Flow Cytometric Analysis	  
 
Cell suspensions were stained with anti-CD8 (FITC); anti-CD4, anti-CD80, anti-
CD40 and anti-Ly51 (PE); anti-CD205 (biotin) antibodies (Abs) and streptavidin 
(PE-Cy7) (Becton Dickinson); anti-I-A/I-E (Alexa780); anti-CD45.2 (PerCPCy5.5); 
anti-EpCAM and anti-CD8 (APC) Abs and anti-EpCAM (eFluor 450) Abs 
(Ebioscience). For cell cycle analysis, staining with propidium iodide (PI) solution 
(Sigma) was done after fixation with cold pure ethanol for 1 hour at 4ºC followed 
by over-night incubation at -20ºC. After PBS-washing, cells were incubated for 30 
minutes at 37ºC with PI staining solution (50 µg/ml PI in PBS with 0.05% Triton X-
100). Analysis was done using both FACSCantoII and FACSAria (BD Biosciences) 
and FlowJo software. Cell sorting was performed using FACSAria (BD Biosciences. 
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Gene Expression	  
 
For quantitative PCR (qPCR), total RNA from sorted cells was purified with an 
RNeasyMicroKit (Qiagen). The quantity of total RNA was assessed using ND-1000 
spectrophotometer (Thermo Scientific). cDNA synthesis was performed by reverse 
transcription of the extracted RNA, using SuperScript III first-strand synthesis 
system for RT-PCR (Invitrogen) and Random Hexamers (Fermentas) according to 
the manufacturer’s instructions. qPCR were performed either using TaqMan 
Universal Master Mix (Applied Biosystems) and primers Hprt, 18s, Il7, Dll4, Ccl25, 
Psmb11, Aire and Tnfrsf11a (RANK) (Applied Biosystems) or iQ™ SYBR® Green 
Supermix (Bio-Rad) with primers specific for β-actin (forward: 5' 
cgtgaaaagatgacccagatca 3'; reverse: 5' tggtacgaccagaggcatacag 3'), Ctss 
(Cathepsin S) (forward: 5' ccattgggatctctggaagaaaa 3'; reverse: 5' 
tcatgcccacttggtaggtat 3'), Tnfsf11 (RANKL) (forward: 5' cacacctcaccatcaatgctgc 3'; 
reverse: 5 gaagggttggcacacctgaatgc 3') and Cd40lg (CD40L) (forward: 5' 
gtgaggagatgagaaggcaa 3'; reverse: 5 cactgtagaacggatgctgc 3') (Sigma). Il7 probes 
used were located between exons 1 and 2, in order to detect only endogenous 
Il7. All the samples were analysed as triplicates and the delta-delta-Ct method 
was used to calculate relative levels of target mRNA normalized to 18s/Hprt or β-
actin. All procedures were performed according to the manufacturer’s protocols. 
Real-time PCR was performed on an iCycler iQ5 Real-Time PCR thermocycler (Bio-
Rad). Data were analysed using iQ5 Optical System software (Bio-Rad). 
 
Fetal Thymic Organ Culture	  
 
E14 fetal thymi were dissected and thymic lobes were separated. Usually, three 
or four lobes were used per condition in order to normalize the intrathymic 
variations. A gel foam sponge was used to support thymic lobes on 0.8 µm 
Isopore membrane filter (Millipore), cultured in 6 well plates with 1ml DMEM 
medium (GIBCO) supplemented with 10% FCS, 1% L-Glutamine 200 mM (GIBCO) 
and 360 mg/L of 2-deoxyguanosine (Sigma) for 4 days. The agonistic anti-RANK 
(αRANK) (5 µg/ml; R&D Systems) or/and the agonistic anti-LTβR mAB AC.H6 (10 
µg/ml; kindly provided by Jeff Browning, Biogenidec, US) was added on day 4. For 
the blocking experiment, the antagonistic anti-RANKL (Prepotech) was added to 
Fetal Thymic Organ Culture (FTOC) at a final concentration of 10 µg/ml on day 0 
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and 4. FTOCs were maintained for 8 days. TECs were isolated (as described 
above) and analysed by flow cytometry. 
 
Immunohistological Analysis	  
 
Thymic lobes were fixed in 4% paraformaldehyde (Electron Microscopy 
Sciences) in PBS, washed twice with PBS and incubated in 50% sucrose-PBS 
solution before being embedded in OCT compound (Sakura) and frozen.  8 µm 
sections, obtained in the Ultramicrotome Leica Reichert SuperNova, were 
collected in Superfrost/Plus slides (Fisher Scientific) and stored at -20ºC. After re-
hydration and blocking (10% BSA in PBS solution), samples were stained with 
rabbit anti-GFP, biotinylated CD205, rat anti-MHC Alexa647 as primary 
antibodies, Alexa Fluor 488 donkey anti-rabbit IgG, Alexa Fluor 647 goat anti-rat 
and streptavidin Alexa 555 as secondary antibodies (Invitrogen). Vectashield 
mounting medium with 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories) 
was used to prepare the slides. Analysis was performed in an AxioImager Z1 (Carl 
Zeiss). Images were processed with Fiji Software. 
 
In Vivo Anti-CD3ε Treatment	  
 
3-4 days old neonatal Rag2-/- mice (less than 3 days) were injected 
intraperitoneally with purified anti-CD3ε monoclonal antibody (mAb) (10 µg/g 
body weight; Clone 1452C11; Kindly provided by Benedita Rocha, Hospital 
Necker, France). Mice thymi were collected 5 or 12 days after injections. For in 
vitro studies, fetal thymic lobes from Rag2-/- fetus (day 14 of gestation) were used 
to establish FTOC with or without 10 µg/ml anti-CD3ε mAb for 5 days. In both 
procedures, TECs were isolated, counted and analysed by flow cytometry 
according the procedures described above. 
 
Statistical Analysis	  
 
Statistical analysis of the results was performed using the GraphPad Prism 
Software. The two-tailed Mann-Whitney test was used to analyse the differences 
between groups. A 95% confidence interval was applied in the calculations and 
samples with p values under 0.05 were considered significant. 
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A Prelude on the ontogeny of IL7hi/YFP+ TECs 
 
Previous studies using IL-7 reporter mice identified a particular population of 
TECs that expresses high levels of Il7 transcripts [89,90]. IL7hi/YFP+TECs appear 
early during fetal development and gradually diminish along gestation 
concomitantly with hematopoietic colonization of the thymus. In addition, 
IL7hi/YFP+TECs segregate from mature CD80+ mTECs throughout development 
indicating that they may constitute a specialized cortical subset [90]. To better 
define the identity of IL7hi/YFP+TECs within the cortical epithelium, we performed a 
combinatory phenotypic-temporal analysis throughout thymic organogenesis 
employing two different cTEC-associated markers, CD205 and BP1 [35]. TECs 
were identified based on the expression of MHCII and EpCAM and the lack of 
CD45 markers accordingly to the gating strategy described in Figure S1. In line 
with previous results, IL7hi/YFP+TECs emerged early during fetal development, in 
which they represented the majority of the thymic epithelium and gradually 
disappeared with age (Figure 6.A and Figure S2, top panel). The maturation of 
TECs could be monitored by the progressive expression of high levels of MHCII 
along thymic development (Figure 6.A). During early stages of thymic 
organogenesis, both IL7hi/YFP+ TECs and YFPneg TECs revealed a similar phenotypic 
pattern, with the majority of cells of both subsets expressing cortical traits 
(CD205+BP1+). However, from E16.5 onwards, while IL7hi/YFP+TECs retained a 
cortical-related phenotype, a subset of medullary epithelium (CD205-BP1-) started 
to emerge within YFPneg TECs (Figure 6.Bi). 
In addition, we analysed the epithelial compartment on the basis of the 
expression of the costimulatory molecule CD40, which was recently associated 
with TECs exhibiting a genetic profile linked to the mTEC lineage [49]. During 
thymic ontogeny, IL7hi/YFP+TECs progressively acquired the expression of CD40 
while retaining the expression of CD205 (Figure 6.Bii). Noticeably, and in 
contrast to IL7hi/YFP+TECs, the increment in the expression of CD40 by YFPneg TECs 
was accompanied by the expression of a medullary-associated marker CD80 
(Figure 6.Biii), suggesting that YFPneg TECs might harbour a putative mTEC 
precursor. 
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Having established that IL7hi/YFP+ TECs retained a cTEC phenotype during thymic 
development, we aimed at investigating its molecular features relatively to 
cortical and medullary-associated genes. To this end, a molecular 
characterization of IL7hi/YFP+ and YFPneg TECs at different time points of thymic 
organogenesis were performed by quantitative PCR using a panel of TEC-
associated genes: Ccl25, a chemokine responsible for the attraction the T cell 
progenitors to the thymus; Dll4, the Notch ligand involved in the commitment 
towards the T cell lineage; Il7, a cytokine that provides survival and proliferative 
signals for developing thymocytes; Psmb11 (β5t), a proteasome subunit involved 
in positive selection; Ctss (Cathepsin S), a lysosomal endoproteinase implicated in 
 
Figure 6 - IL7hi/YFP+ TECs emerge during early thymic organogenesis and comprise an epithelial population that 
displays cortical-associated traits. Thymi from IL-7 reporter mice (Tg) were analyzed at the indicated time points. A) 
Dynamics of IL7hi/YFP+ TECs (gated on CD45-/MHCII+/EpCAM+) (top panel). B) Phenotypic characterization of TECs 
throughout fetal development using a panel of cTEC and mTEC-associated markers. i) BP1 and CD205. ii) CD40 and 
CD205 and iii) CD40 and CD80. The FACS plots in B represent an overlay of color-coded IL7hi/YFP+ (green dot plot) and 
YFPneg (gray contour plot) TECs shown in A. A and B) Numbers indicate the percentage of gated cells. For B, numbers in 
green represent the percentage of gated cells within IL7hi/YFP+ TECs. 
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negative selection; Tnfrsf11a (RANK), a TNFSF member responsible for mTEC 
differentiation and Aire, the transcription factor that mediate the expression of 
TRA during negative selection [12,34,35].   
In line with the phenotypic characterization (Figure 6), similar levels of 
cortical-associated transcripts (Ccl25, Dll4, Il7 and Psmb11) were found in both 
IL7hi/YFP+ and YFPneg TECs at early stages of thymic organogenesis (E14-16) (Figure 
7, top panel). However, as the compartmentalization into distinct TEC 
microenvironments began, differences in the expression pattern between both 
subsets became more prominent, with IL7hi/YFP+ TECs retaining the expression of 
cortical-associated genes (Figure 7, top panel). Regarding the medullary-
associated genes, the expression of Ctss, Tnfrs11a and Aire was virtually 
undetected in IL7hi/YFP+ TEC fraction. Yet, these transcripts were already present in 
YFPneg TECs at E14-16, particularly Ctss and Aire, and progressively increased 
throughout thymic ontogeny (Figure 7, bottom panel). Taken together, our 
results suggest that IL7hi/YFP+ TECs are a determinant of the cortical lineage and 
segregate from mature mTECs expressing Ctss, Tnfrs11a and Aire. 
 
 
 
 
 
 
 
 
YFPneg  IL7hi/YFP+  
Fo
ld
 d
iff
er
en
ce
 
R
el
at
iv
e 
m
R
N
A 
le
ve
ls
 
Psmb11 
 (β5t) 
 
* 
* 
Dll4 
 
* 
* 
Nb E17-18 2wks E14-16 
Ccl25 
 
* 
* 
Il7 
* * * 
Nb E17-18 2wks E14-16 Nb E17-18 2wks E14-16 Nb E17-18 2wks E14-16 
* * 
Cortical-associated genes 
0
4
8
12
0
4
8
12
Fo
ld
 d
iff
er
en
ce
 
R
el
at
iv
e 
m
R
N
A 
le
ve
ls
 
2wks 
Aire 
* 
* 
* 
Nb E17-18 E14-16 E17-18 E14-16 
Ctss 
(Cathepsin S) 
E17-18 E14-16 
Tnfrsf11a 
(RANK) 
* 
* * 
* 
Nb Nb 
Medullary-associated genes 
 
Figure 7 - Molecular characterization of YFPneg and IL7hi/YFP+ TECs during thymic ontogeny. YFPneg (gray) and IL7hi/YFP+ 
TECs (green) purified at the indicated time points were analyzed for the expression of Ccl25, Dll4, Il7, Psmb11 (β5t), 
Ctss (Cathepsin S), Tnfrsf11a (RANK) and Aire. Values were normalized to 18s, Hprt or ß-actin. IL7hi/YFP+ TECs were set 
as 1, at each time point, and the fold difference in the relative mRNA expression was compared to YFPneg TECs. Average 
values of 4-6 independent experiments are shown. (*) indicates that the difference between groups are statistically 
significant (p<0.05). 
Chapter III | Results 
	  30 
Thymocyte-derived signals modulate the homeostasis of 
IL7hi/YFP+ TECs 
 
It was previously reported that the frequency of IL7hi/YFP+ TECs was strikingly 
augmented when thymocyte development was abrogated in Rag2-/-Il2rg-/- mice 
[90]. Nevertheless, reconstitution of Rag2-/-Il2rg-/- mice with BM-progenitors from 
WT and TCRα-/- mice diminuished the frequency of IL7hi/YFP+ TECs, suggesting that 
this population is controlled by thymocyte-derived signals [90]. Given this 
interdependence, the usage of mouse mutants with a defective T cell 
development may constitute a good tool to study the mechanisms underlying the 
homeostasis of IL7hi/YFP+ TECs. Thus, we crossed IL-7 reporter mice into a Rag- 
deficient background [108], in which T cell development is blocked at the DN3 
stage due to the absence of rearrangement of the TCR [11].  
To study the developmental dynamics of IL7hi/YFP+ TECs under this lymphopenic 
conditions, we performed a combinatory kinetic analysis employing cortical and 
medullary markers, CD205 and CD80, respectively. TECs were identified using 
the same gating strategy as described above (Figure S1). During early stages of 
development, IL7hi/YFP+ TECs from Rag2-/- mice revealed a developmental 
progression similar to those observed in age-matched immunocompetent mice, in 
which TECs gradually acquired higher levels of expression of MHCII (Figure 8.A). 
However, contrarily to immunocompetent mice, IL7hi/YFP+ TECs were markedly 
sustained during post-natal life (Figure 8.A and Figure S2, bottom panel). In 
Rag2-/- mice, due to the lack of instructive signals provided by developing 
thymocytes, the maturation of CD80+ mTEC was severely impaired. In fact, 
throughout thymic development, the thymic epithelium displayed a predominant 
cortical-like CD205+ phenotype (Figure 8.B).  Thus, these results suggest that 
IL7hi/YFP+ TECs are maintained under lymphopenic conditions and their homeostasis 
might be modulated by the crosstalk with thymocytes that progress beyond the 
DN3 stage. 
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Next, we addressed whether a defective T cell developmental programme 
modulated the molecular features of both IL7hi/YFP+ and YFPneg TECs. To this 
purpose, the gene expression profile of both populations was assessed by 
quantitative PCR, during embryonic and young post-natal developmental stages, 
using a similar panel of TEC-associated genes as previously described in 
immunocompetent mice (Figure 7).  
In contrast to gene expression pattern observed in immunocompetent mice, 
both IL7hi/YFP+ and YFPneg TECs were found sustain comparable levels of cortical-
associated genes (Ccl25, Dll4, Il7 and Psmb11) during thymic ontogeny (Figure 9, 
top panel). Interestingly, during early stages of thymic development, the 
expression of medullary-associated Ctss, Tnfrs11a and Aire was already detected 
 
Figure 8 - IL7hi/YFP+ TECs are sustained when thymocyte development is abrogated at DN3 stage. Thymi from Rag2-/- 
IL-7 reporter mice were analysed at the indicated time points. A) Dynamics of IL7hi/YFP+ TECs (gated on CD45-
/MHCII+/EpCAM+). B) Phenotypic characterization of TECs throughout ontogeny using cTEC and mTEC markers, CD205 
and CD80. Top panel represents the general pattern of TECs. Bottom panel represents an overlay between the color-
coded IL7hi/YFP+ (green dot plot) and YFPneg (gray contour plot) TECs. A and B) Numbers indicate the percentage of gated 
cells. For B, numbers in green represent the percentage of gated cells within IL7hi/YFP+ TECs. 
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within the YFPneg TEC fraction (Figure 9, bottom panel), reinforcing the idea for 
the existence of a pre-committed mTEC precursor within this subset. However, 
during post-natal life, and in contrast to immunocompetent mice, the expression 
of medullary-associated genes were not steadily augmented, particularly Ctss and 
Tnfrs11a, consistently with an impaired mTEC differentiation that result from the 
lack of mature thymocyte-derived signals (Figure 9, bottom panel). Together, 
these results suggest that in Rag2-/- thymus, both Il7hi/YFP+ and YFPneg TECs retain an 
immature molecular profile. 
	   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Previous studies have described that TECs display a higher proliferative 
capacity during early stages of development, which gradually decline as their 
maturation proceeds [105]. We next examined whether IL7hi/YFP+ and YFPneg TECs in 
Rag2-/- mice differ in their proliferative status using propidium iodine (PI) staining 
and comparing TEC isolated from normal and lymphopenic conditions throughout 
development. During early phases of thymic ontogeny, IL7hi/YFP+ TECs showed a 
higher frequency of cycling cells compared with YFPneg TECs counterparts in both 
 
Figure 9 - Thymic epithelium of Rag2-/- mice exhibit a predominant cortical-associated molecular profile. YFPneg 
(gray) and IL7hi/YFP+ TECs (green) purified at the indicated time points were analyzed for the expression of Ccl25, Dll4, 
Il7, Psmb11 (β5t), Ctss (Cathepsin S), Tnfrsf11a (RANK) and Aire. Values were normalized to 18s, Hprt or ß-actin. 
IL7hi/YFP+ TECs were set as 1, at each time point, and the fold difference in the relative mRNA expression was compared 
to YFPneg TECs. Average values of 2-4 independent experiments are shown. (*) indicates that the difference between 
groups are statistically significant (p<0.05). 
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immunocompetent and Rag2-/- mice (Figure S3). However, a gradual decline in the 
proliferative potential of TECs was observed in normal and lymphopenic 
conditions, with both TEC subsets displaying similar frequencies of cycling cells 
during later stages of development (Figure S3). Overall, these results suggest 
that variations in proliferative status of TECs during development dissociate from 
the TEC differentiation programme induced by T cells. 
 
The progressive thymocyte-induced decline of IL7hi/YFP+ TECs is 
independent from the maturation of mTECs 
 
We observed an interesting inverse correlation between the dynamics of 
IL7hi/YFP+ TECs and YFPneg mTECs. While in normal conditions the gradual decay of 
IL7hi/YFP+ TECs was accompanied by the emergence of YFPneg mTECs (Figure 10.A), 
in Rag2-/- mice, in which mTEC formation was stalled, the frequency of IL7hi/YFP+ 
TECs was maintained along development (Figure 10.B). Such evidence led us to 
hypothesize that, although IL7hi/YFP+ TECs displayed a cortical-related phenotypic 
and molecular profiles, this TEC population might have a direct progenitor-
precursor lineage relationship with mTECs. 
 
 
As aforementioned, the cooperative action of TNFSF members ensures the 
establishment of fully competent medullary microenvironment [34,37]. While 
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Figure 10 - IL7hi/YFP+ and YFPneg TECs exhibit distinct developmental kinetics under normal and immunodeficient 
conditions. Graphs represent the percentage of gated cells for IL7hi/YFP+ TECs (green line), YFPneg cTECs (blue line) and 
YFPneg mTECs (red line) at the indicated time points. A) Immunocompetent mice and B) Rag2-/- mice. Average values of 
5-8 independent experiments are shown for each time point. 
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LTβR and RANK-mediated signals are the major mediators in the initial phase of 
mTEC differentiation during embryogenesis, CD40 signals exert their effect 
beyond post-natal life. Given that IL7hi/YFP+ TECs disappeared as mTECs emerged, 
we investigated whether signalling through TNFSF members, particularly by LTβR 
and RANK, impacted in the maintenance of IL7hi/YFP+ TECs. To address this 
possibility, we used an in vitro organotypic cultures named Fetal Thymic Organ 
Culture (FTOC). In this technique, the colonization of the thymus with BM-
progenitors is blocked. Still, a complete programme of T cell development is 
supported, eliciting the normal differentiation of the thymic microenvironment 
into mature cTECs and mTECs [111]. 
Since RANK has been described as the most important TNFSF member involved 
in the optimal differentiation of CD80+Aire+ mTECs [100,102], we started by 
analysing its influence in the dynamics of IL7hi/YFP+ TECs. E14 FTOC was established 
in the presence or absence of thymocytes. In order to remove the endogenous 
contribution of thymocyte-derived signals in the development of the thymic 
epithelium, FTOCs were treated with 2-deoxyguanosine (dGuo). The effect of 
inhibiting RANK-mediated signals was addressed by addition of a blocking anti-
RANKL antibody (anti-RANKL, αRANKL) to FTOC. In dGuo-treated FTOC, in which 
thymocytes were selectively depleted, IL7hi/YFP+ TECs were markedly maintained 
and the formation of mTECs was impaired (Figure 11, left panel). After 8 days of 
FTOC, the medullary epithelium started to develop and both the intensity of YFP 
activity and the frequency of IL7hi/YFP+ TECs diminished (Figure 11.A, middle 
panel), resembling the phenotype observed during later stages of fetal thymic 
development in vivo. Yet, although inhibition of RANK-mediated signals in FTOC 
completely blocked the formation of mTECs (Figure 11.A, right panel), the 
thymocyte-induced decay in IL7hi/YFP+ TECs was still observed (Figure 11.A, right 
panel). These changes in IL7hi/YFP+ TECs became clear when the mean fluorescent 
intensities (MFI) of this subset for the different conditions were represented 
(Figure 11.B and C). 
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To confirm that RANK-derived signals do not affect the homeostasis of IL7hi/YFP+ 
TECs, we performed a complementary experiment in which the effect of direct 
stimulation of RANK signalling pathway in TECs was examined. An exogenous 
activator of RANK (agonistic anti-RANK, αRANK) was added to E14 thymocyte-
depleted FTOC (dGuo-treated FTOC). RANK stimulation led to the appearance of 
CD80+ mTECs with a concomitant reduction in the frequency of IL7hi/YFP+ TECs. Yet, 
in contrast to FTOC, RANK activation did not induce the decay in the intensity of 
YFP expression in IL7hi/YFP+ TECs (Figure 12.A, middle panel) suggesting that 
IL7hi/YFP+ TECs are not responding to RANK and therefore, may not define a direct 
progeny of RANK-induced mTECs. 
As previously alluded (Figure 7, bottom panel), despite the early expression of 
RANK detected already in TECs at E14, its expression levels were steadily 
increased from E17 onwards, namely in YFPneg TECs. To test a possible correlation 
between the amounts of RANK transcripts and the responsiveness of TECs to 
 
Figure 11 - Blockade of thymocyte-derived RANKL does not influence the thymocyte-mediated decline of IL7hi/YFP+ 
TECs. E14 thymic lobes were left untreated (FTOC) and treated with deoxyguanosine (dGuo FTOC), in the presence or 
absence of blocking antibody for RANKL (αRANKL) A) TECs were analyzed for the expression of YFP (top panel) and BP1 
and CD80 (middle and bottom panels) (representative experiment). The middle panel shows total TEC gate, whereas 
the bottom panel represents an overlay of YFPneg (gray) and IL7hi/YFP+ (green) TECs. B) Histogram representation of the 
YFP expression for the different conditions represented in A. C) Data represents the average of the fold difference in 
the Mean Fluorescence Intensity (MFI) of YFP (left). The MFI of the expression of YFP in IL7hi/YFP+ TECs from thymi treated 
with dGuo was set as 1. The percentage of IL7hi/YFP+ TECs and CD80+ TECs after FTOCs is represented on the middle and 
right graph, respectively. (*) indicates that the differences between groups are statistical significant (p<0.05). 
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RANK signals, RANK-stimulated dGuo-treated FTOC were established with E17 
lobes. In accordance with the prior observations, no change was observed in the 
intensity of YFP expression in Il7hi/YFP+ TECs upon activation with agonistic αRANK 
(Figure S4, middle panel). These results indicate that IL7hi/YFP+ TECs are 
continually unresponsive to RANK-derived signals. 
A recent study has described the existence of a synergistic effect between LTβR 
and RANK in the formation of the thymic medulla during embryogenesis. In 
particular, LTβR-mediated signals enhance the expression of RANK in mTECs 
leading to an increase in the responsiveness of the thymic epithelium to 
thymocyte-derived RANKL [98]. Since RANK signalling per se did not affect the 
homeostasis of IL7hi/YFP+ TECs, we tested whether the cooperative action of LTβR 
and RANK-derived signals modulated IL7hi/YFP+ TECs. E14 dGuo-treated FTOC were 
cultured in the presence of αRANK, an agonistic antibody anti-LTβR (αLTβR) or the 
combination of both. Stimulation through the LTβR alone did not affect either the 
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Figure 12 - Thymocyte-mediated decrease in IL7hi/YFP+ TECs is independent of mTEC differentiation induced by 
RANK signaling. E14 thymic lobes were left untreated (FTOC) and treated with deoxyguanosine (dGuo FTOC), in the 
presence or absence of an agonistic antibody for RANK (αRANK) A) TECs were analyzed for the expression of YFP (top 
panel) and BP1 and CD80 (middle and bottom panels) (representative experiment). The middle panel shows total TEC 
gate, whereas the bottom panel represents an overlay of YFPneg (gray) and IL7hi/YFP+ (green) TECs. B) Histogram 
representation of the YFP expression for the different conditions represented in A. C) Data represents the average of 
the fold difference in the Mean Fluorescence Intensity (MFI) of YFP (left). The MFI of YFP expression in IL7hi/YFP+ TECs 
from thymi treated with dGuo was set as 1. The percentage of IL7hi/YFP+ TECs and CD80+ TECs after FTOC is represented 
on the middle and right graph, respectively. (*) indicates that the differences between groups are statistical significant 
(p<0.05). 
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intensity of IL7hi/YFP+ TECs or the mTEC development (data not shown). The 
combined αRANK and αLTβR stimulation induced an increase in CD80+ mTECs 
comparatively with αRANK activation. Still, in these circumstances, despite 
changes in the frequency of IL7hi/YFP+ and YFPneg TECs, the YFP expression driven by 
the activity of Il7 promoter was maintained in IL7hi/YFP+ TECs (Figure S5).  
Collectively, our data indicate that IL7hi/YFP+ TECs are regulated by thymocyte-
dependent interactions that dissociate from RANK- and LTβR-mediated maturation 
of mTECs. 
 
DP thymocytes devoid of TCR expression are not sufficient to 
induce the decay of IL7hi/YFP+ TECs   
 
During early T cell development, the progression of immature DN3 thymocytes 
into the DP stage is largely dependent on the expression of a functional pre-TCR, 
a complex composed by a rearranged TCRβ chain plus an invariant pre-TCRα 
chain coupled to accessory CD3 molecules [11]. Cell-autonomous signalling 
through the pre-TCR governs the β-selection developmental checkpoint [112], a 
process that ensure that only thymocytes bearing a productive in frame TCRβ 
chain are able to survive and differentiate beyond the DN3 stage [59]. In line with 
previous observations [90], our findings highlight that IL7hi/YFP+ TECs are negatively 
influenced by signals provided by thymocytes that progress beyond the β-
selection stage. Given the importance of this checkpoint during T cell 
development, we evaluated whether the TEC-thymocyte crosstalk during β-
selection might contribute to the gradual decay of IL7hi/YFP+ TECs during thymic 
development. To do this, we took advantage of pre-TCR activation model using 
Rag2-/- mice treated with anti-CD3ε mAb. In these mice, anti-CD3ε activation 
mimics the pre-TCR signal transduction events that occur during β-selection in 
normal mice, consequently promoting the generation of DP thymocytes that are 
however, devoid of pre-TCR/TCR expression [113]. 
Neonatal Rag2-/- mice were intraperitoneally injected with anti-CD3ε mAb, being 
the treatment subsequently reinforced with a new injection of antibody 5 days 
later. Upon anti-CD3ε mAb administration, Rag2-/- thymi revealed a great 
expansion either in size (Figure S6.A) and thymic cellularity (Figure S6.B), 
reaching comparable number of thymocytes on day 12 post-treatment as 
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observed in age-matched immunocompetent thymi. In Rag2-/- treated mice, DN3 
thymocytes transverse the β-selection into the DP stage but were not positively 
selected due to the lack of TCR expression (Figure S6.C). Of note, a significant 
increase in the absolute numbers of DN, ISP8 and DP subsets was observed 12 
days after anti-CD3ε mAb stimulation in comparison to day 5 post treatment 
(Figure S6.D). 
Next, we characterized the impact of the abnormal crosstalk between DP 
thymocytes devoid of TCR and TECs in the differentiation of the thymic 
epithelium. We observed that the thymocyte-induced decay in IL7hi/YFP+ TECs, 
measured both by the drop in the frequency and in the intensity of the YFP 
reporter activity, was attenuated in anti-CD3ε treated thymi comparatively to age-
matched immunocompetent thymi (Figure 13.A, middle and right panel). 
Treated mice revealed a conspicuous improvement of the thymic epithelial 
microenvironment, with the emergence of CD80+ mTECs within the YFPneg 
compartment (Figure 13.A, middle panel). The transcriptional profile of these 
newly generated mTECs revealed an increased expression of medullary-related 
Ctss, Tnfrs11a and Aire (Figure S7). Still, despite the evident increased of CD80+ 
mTECs in treated mice, their representation did not reach the levels observed in 
age-matched immunocompetent mice (Figure 13.A, middle and right panel; 
Figure 13.C, right graph), suggesting that anti-CD3ε mAb treatment only 
partially restored mTEC differentiation. To confirm that the expansion of 
Aire+CD80+ mTECs was not due to a direct consequence of anti-CD3ε mAb 
stimulation in thymic epithelium, E15 thymic lobes were place in a dGuo-treated 
FTOC and supplemented with anti-CD3ε mAb. The development of CD80+ mTECs 
was not induced in this situation (Figure S8), demonstrating that the TEC-
thymocyte crosstalk that occurred during DN-DP transition was responsible for 
promoting mTEC development.  
Together, our data indicate that induction of DP thymocytes that lack TCR 
expression do not substantially curtail IL7hi/YFP+ TECs and suggest that TCR-MHC 
interactions between thymocytes and TECs during thymocyte selection define a 
novel checkpoint in the control of the homeostasis of the cortical epithelium. 
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Given the development of Aire+ CD80+ mTECs that occurred concomitantly with 
the emergence of DP thymocytes, we next sought to investigate the molecular 
mechanisms behind this phenomenon. The expression level of TNFSF members 
involved in mTEC development, particularly RANKL and CD40L, was analysed by 
qPCR in different purified thymocyte populations isolated from Rag2-/- anti-CD3ε 
treated mice. In line with previous observations [100], Tnfsf11 (RANKL) was 
expressed predominantly in CD4+ SP thymocytes, although its expression was also 
detected within DN thymocytes (Figure S9.A). Upon anti-CD3ε treatment, DN, 
ISP8 and DP thymocytes from Rag2-/- mice expressed similar levels of Tnfsf11 
(Figure S9.A). Furthermore, in contrast to the higher levels of Cd40lg (CD40L) 
expressed by CD4+ SP thymocytes, the expression of this transcript was hardly 
found in DN, ISP8 and DP thymocytes isolated from treated mice (Figure S9.B). 
Overall, these results suggest that differentiation of medullary epithelial 
compartment following anti-CD3ε treatment is not associated with an increase in 
the expression levels of RANKL and CD40L by DP thymocytes. 
 
Figure 13 - DP thymocytes deficient in TCR expression do not profoundly affect IL7hi/YFP+ TECs. Neonatal Rag2-/- 
mice were injected intraperitoneally at the third day after birth with 10µg/g of purified anti-CD3ε mAb and analysed 
twelve days after treatment. A) TECs were analyzed for the expression of YFP (top panel) and BP1 and CD80 (middle 
and bottom panels) (representative experiment). The middle panel shows total TEC gate, whereas the bottom panel 
represents an overlay of YFPneg (gray) and IL7hi/YFP+ (green) TECs. B) Histogram representation of the YFP expression for 
the different conditions represented in A. C) Data represents the average of Mean Fluorescence Intensity (MFI) of YFP 
(left), the frequency of IL7hi/YFP+ TECs (middle) and the percentage of CD80+ TECs after anti-CD3ε mAb administration, 
comparing with an age-matched immunocompetent mice. (*) indicates that the differences between groups are 
statistical significant (p<0.05). 
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Next, we characterized the spatial alterations that occurred within the thymic 
microenvironment upon anti-CD3ε treatment. Thymic sections from either control 
or treated Rag2-/- mice were analysed by immunohistochemistry using a panel of 
specific antibodies against hematopoietic and TEC markers. Cortical and 
medullary TECs were identified on the basis of the differential expression of 
MHCII, which is more expressed by mTECs [47,114], CD205 and MTS10, which 
represent a cortical and medullary-associated marker, respectively [34,35]. In line 
with the results obtained from flow cytometry analysis, Rag2-/- epithelium revealed 
a predominant cortical-associated phenotype (MHCII+ and CD205+) (Figure 14, 
middle panel), although with the presence of few scattered MTS10+ mTECs 
(Figure 14, right panel). The emergence of ISP8 and DP thymocytes in treated 
mice, identified by CD8 immunostaining (Figure 14, left panel), was 
accompanied by the segregation of thymic epithelium, with the development of 
small MHCII+ and MTS10+ medullary islets (Figure 14, middle and right panel). 
Yet, the spatial distribution of medullary areas in treated mice differed from 
those observed in immunocompetent mice, with smaller medullary foci in treated 
thymi (Figure S10). These observations indicate that anti-CD3ε treatment elicits a 
partial differentiation of TECs in Rag2-/- mice. 
 
Figure 14 - Anti-CD3ε  treatment improves TEC compartmentalization in Rag2-/- mice. Representative 
immunohistochemical analysis of thymic sections obtained either from non-treated and αCD3ε treated Rag2-/- IL-7 
reporter mice. Sections were stained with the following antibodies: YFP, green; CD8, red (left panel); YFP, green; 
CD205, red; MHCII, blue (middle panel); DAPI, blue; YFP, green; MTS10, red (right panel). 
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The development of cTECs constitutes a primitive hallmark event in the 
establishment of a functionally competent thymic niche, essential for attraction, 
lineage specification and subsequent selection of T cell precursors [12,34,35]. 
However, little is known with regard to the underlying mechanisms regulating 
cTEC homeostasis. In this thesis, taking advantage of IL-7 reporter mice, we 
performed an extensive cellular and molecular characterization of IL7-expressing 
TECs during thymic ontogeny to gain insights into this poorly understood issue. 
The partitioning of the thymic epithelial microenvironment into two specialized 
subpopulations of cTECs and mTECs is a highly dynamic process initiated early 
during fetal development and proceeding throughout post-natal life [8,22]. Our 
analyses indicate that IL7hi/YFP+ TECs emerge early during thymic organogenesis, 
retain a cortical-associated phenotype while continually segregating from mature 
YFPneg mTECs. Furthermore, IL7hi/YFP+ TECs are markedly sustained in 
immunodeficient Rag2-/- mice, in which T cell development is blocked at the DN3 
stage, indicating that their homeostasis is regulated by thymocyte-derived signals 
beyond the DN3 stage. A recent report has proposed a conceptual model that 
defines distinct stages of cTEC differentiation based on the differential 
expression of CD205 and CD40 markers [49]. Our findings demonstrate that 
IL7hi/YFP+ TECs express early cTEC-associated marker CD205 already at E13.5, and 
progressively acquire the expression of CD40 throughout thymic ontogeny. 
Moreover, although the thymocyte-TEC crosstalk dynamically regulates IL7hi/YFP+ 
TECs, in Rag2-/- mice the sequential acquisition of CD205 and CD40 markers by 
this population is still observed (data not shown). This indicates that while the 
initial programming of cTEC development occurs in a thymocyte-independent 
manner, the differentiation of thymocytes until the DN3 stage permits IL7hi/YFP+ 
TECs to mature through differential stages of cTEC development, culminating 
with the expression of CD205 and CD40. However, due to the paucity of suitable 
markers to identify further transitional stages of cTEC differentiation, one cannot 
exclude that maturation of IL7hi/YFP+ TECs might progress beyond the stage of 
CD205+CD40+ expression. As such, it is acceptable to propose that our mice 
model may provide a useful platform to delineate new transitional stages of cTEC 
development.  
Genetic profiling revealed that IL7hi/YFP+ TECs express cortical-associated 
thymopoietic factors, namely Ccl25 (thymic homing), Dll4 (T cell commitment), IL-
7 (survival and proliferation) and β5t (positive selection), but not medullary-
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associated genes (Aire, Ctss and Tnfrs11a). These thymopoietic signals, provided 
to thymocytes during early stages of thymopoiesis, are detected already during 
early phases of thymic development and are continuously expressed by IL7hi/YFP+ 
TECs. Interestingly, although YFPneg TECs exhibit the expression of cortical-
associated transcripts at early stages of thymic organogenesis, as thymocyte 
development proceeds and the bidirectional thymocyte-TEC interactions occur, 
the segregation between both TEC subsets is accompanied by the upregulation of 
medullary-associated genes within YFPneg TEC fraction. However, under 
lymphopenic conditions, although some medullary traits can be found within 
YFPneg TEC, both IL7hi/YFP and YFPneg TEC subsets display a predominant immature 
molecular profile, similar to those observed for immunocompetent mice at early 
stages of thymic ontogeny. Therefore, one can hypothesize that IL7hi/YFP+ TECs 
might represent a specialized cortical-associated TEC population that support 
early stages of thymopoiesis, whereas YFPneg TECs are responsible for generating 
medullary TECs governing later stages of T cell development. In the future, a 
genome wide approach to identify particular markers either for IL7hi/YFP+ and YFPneg 
TECs accompanied by the analysis of the impact of cell type-specific ablation in 
thymopoiesis may permit to dissect the capacity of each population to support 
distinct stages of T cell development. 
Recent findings have shed some light on the lineage relationship between 
cTECs and mTECs. It is currently accepted that both subsets derive from a 
common bipotent precursor and diversify through intermediate-compartment 
specific progenitors [45,46,48,49]. As such, given the particular phenotypic and 
molecular patterning between both subsets observed along thymic development, 
we can propose two distinct models in order to explain the lineage relationship 
between IL7hi/YFP and YFPneg TECs. In the first model, one can envisage that IL7hi/YFP 
and YFPneg TECs might represent (or derive from) distinct compartment-
intermediate progenitors. While IL7hi/YFP TECs define a progenitor subset 
committed into the cortical lineage, YFPneg TECs might arise sharing combined 
"cortical and medullary" features and, depending on thymocyte-derived signals 
provided at distinct stages of T cell development, differentiate into either cTECs 
or mTECs lineages. In our second model, IL7hi/YFP TECs emerge as a unique TEC 
lineage that posteriorly converts into YFPneg cortical and medullary TECs. Further 
studies employing reaggregate thymic organ culture (RTOC), in which purified 
TECs and different thymocyte subsets are allow to interact in vitro to generate a 
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new thymic microenvironment [111], will prove to be useful to unveil the lineage 
diversification among YFPneg and IL7hi/YFP+ TECs. 
Thymic involution is a conspicuous physiological process characterized by 
multiple phenotypical and structural changes within the thymic microenvironment 
[106]. Although the mechanisms behind this phenomenon remain to be 
addressed, the gradual decay in the proliferative status of stromal epithelial 
niches has been described as one of the possible causes that lead to involution 
[105,106]. Our results indicate that IL7hi/YFP+ TECs display a higher turnover during 
early stages of thymic development. This might suggest that IL7hi/YFP+ TECs 
contribute for the initial establishment of a functional thymic microenvironment, 
thereby making it more proficient to harbour and instruct the earliest thymic 
progenitors. Yet, the frequency of cycling cell in both TEC subsets decays and 
becomes progressively similar in later stages of thymic development. The TEC 
turnover is, however, continuously required to maintain the functionality of 
thymic niche to support the development of T cells. Interestingly, we observed a 
similar TEC proliferative kinetics in immunodeficient Rag2-/- mice indicating that 
the TEC proliferative capacity is not substantially affected by the presence of 
developing thymocytes. The gradual lost in TEC proliferative capacity can be 
regulated by epithelial-mesenchymal interactions. It is currently known that NC-
derived mesenchymal cells play an essential role in the expansion of the thymic 
microenvironment during fetal development, by providing proliferative signals to 
TECs, such as FGF-7/10 and IGF-1/2 [21,24]. Additionally, a recent report has 
shown that production of Retinoic acid (RA) by mesenchymal cells, in both 
embryonic and adult thymus, negatively regulates the proliferative capacity of 
TECs, being this effect more pronounced within cortical epithelial compartment 
[23]. Therefore, one can hypothesize that the gradual decline observed in the 
proliferative capacity of IL7hi/YFP TECs is controlled by RA-derived signals provided 
by mesenchyme. Alternatively, we can consider the existence of TEC-intrinsic 
mechanisms involved in regulating cell cycle progression in TECs. In fact, another 
recent study has identified Spatial (also known as Tbata) as a negative modulator 
of thymic stromal cell proliferation [115]. In addition to Tbata, the transcription 
factor p63 was also described as essential to maintain the proliferative potential 
of TEC precursors [116]. Given all these observation, it is acceptable to presume 
that a balance between autonomous and non-autonomous mechanisms might 
control the proliferative capacity of TECs. It would be interesting to assess in the 
future the expression of Tbata and p63 in TEC subsets as well as to study the 
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effect of mesenchyme-derived RA signalling in the clonogenic potential of YFPneg 
and IL7hi/YFP+ TECs.  
During thymopoiesis, the bidirectional interactions between TECs and 
thymocytes are responsible for shaping the cortical and medullary epithelium in a 
stepwise fashion. In fact, it has been currently described that thymocyte-derived 
signals transmitted trough the TNFSF members RANK, LTβR and CD40 
cooperatively contribute for the establishment of a fully competent medullary 
microenvironment [97,98,100]. From all these three, RANK-mediated signalling 
has the strongest impact in mTEC development, particularly by fostering the 
differentiation of Aire-expressing cells [100,102]. Recently, it has been described 
that RANK signals also increase the expression of IL-7 in TECs [117]. Our results 
show that the effect of RANK and LTβR appears to be restricted to TECs that do 
not report YFP (YFPneg TECs) without substantially affecting the homeostasis of 
IL7hi/YFP+ TECs. These observations are in line with previous reports, in which mice 
with defects in the TNFSF signalling pathway exhibit an abnormal medulla but a 
normal cortex [97,98]. Therefore, our findings infer that IL7hi/YFP+ TECs do not 
define a direct progeny of YFPneg CD80+ mTECs, but rather define a cortical 
epithelial lineage regulated by thymocyte-derived TNFSF-independent signals. 
This conclusion favours the model of TEC development in which IL7hi/YFP+ and YFPneg 
TECs define distinct compartment-specific TEC lineages. Although we predict that 
YFPneg TECs emerge sharing combined "cortical and medullary" features, we 
cannot rule out the existence of some heterogeneity within this population. It 
would be interesting to further analyse the cell surface expression of early 
specific markers for cortical and medullary compartment-specific progenitors in 
YFPneg TECs, such as CD205, cytokeratin 8 and claudins 3/4, cytokeratin 5, 
respectively [40,48,49]. 
It has been previously demonstrated that IL-7 expression by TECs is initiated 
independently of thymocyte-derived signals, but during later stages of thymic 
ontogeny, its expression is dynamically regulated by different thymocyte subsets 
[91]. In line with this observation, studies from the host laboratory and from this 
present thesis validate that the homeostasis of IL7hi/YFP+ TEC is controlled by 
signals delivered by thymocytes beyond DN3 stage. Exploiting the potential of an 
anti-CD3ε mAb treatment in Rag2-/- mice, which promotes the progression of DN3 
thymocytes into the DP stage by mimicking the pre-TCR signalling [113], we show 
that the emergence of DP thymocytes devoid of TCR moderately mitigate the 
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frequency of IL7hi/YFP+ TECs. Surprisingly, our findings showed that the TEC-
thymocyte interactions generated upon anti-CD3ε treatment induce a partial 
improvement in the segregation of the thymic epithelium in Rag2-/- mice, with the 
differentiation of CD80+ mTECs. In agreement with our findings, Marrella and 
colleagues recently report, that anti-CD3ε stimulation improves TEC 
compartmentalization in mice model of Omenn syndrome (associated with 
hypomorphic mutations in RAG2 enzyme) [118]. However, while in their study 
very few Aire+ mTECs were detected, our results demonstrate that the 
development of CD80+ mTECs is accompanied by an increase in the expression of 
medullary-related Ctss, Tnfrs11a and Aire transcripts. One possible explanation 
for this discrepancy may be due to different methodologies used to measure Aire 
expression levels. While Marrella and colleagues employed an immunohistological 
approach and quantified the amounts of Aire protein, we analyse the expression 
of Aire transcripts by qPCR in the newly generated mTECs. Interestingly, the 
differentiation of medullary epithelial compartment upon anti-CD3ε treatment do 
not seem to be linked with an increase in the expression levels of RANKL and 
CD40L transcripts by different thymocyte subsets (DN, ISP8 and DP) isolated from 
treated mice. Instead, given the great expansion in thymic cellularity following 
anti-CD3ε administration, we postulate that mTEC development results from an 
increase in the absolute number of RANKL-expressing DN and ISP8 thymocytes. 
Despite the beneficial impact of anti-CD3ε treatment in restructuring the thymic 
epithelium, our analyses reveal that the size of medullary islets in treated mice is 
defective compared to immunocompetent thymus. The partial effect of anti-CD3ε 
stimulation in mTEC differentiation might reflect the need of further instructive 
signals provided by mature thymocytes [100,119]. 
Our findings suggest that in Rag2-/- anti-CD3ε treated mice, the transversion of 
DN3 thymocytes into the DP stage moderately affect IL7hi/YFP+ TECs. A possible 
explanation for this result may rely on the distinct cellular and molecular features 
between DP thymocytes generated in anti-CD3ε treated Rag2-/- mice and those 
generated during a normal physiological conditions. Previously, it has been 
described that DP thymocytes induced upon anti-CD3ε stimulation exhibit 
molecular intermediate characteristics between DN and DP thymocytes [120]. In 
addition, these DP thymocytes cannot undergo positive selection due to the lack 
of TCR expression and consequently interact with the thymic epithelium in TCR-
independent manner. In line with this observation, we predict that DP thymocytes 
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from anti-CD3ε treated mice do not substantially impact on the homeostasis of 
IL7hi/YFP+ TECs due to the absence of TCR-dependent interactions. Currently, we are 
studying whether TCR-mediated signals generated during thymocyte selection 
control the maintenance of IL7hi/YFP+ TECs. To address this question, we are 
currently examining the thymi of Marilyn TCR transgenic Rag2-/- mice with 10-14 
days old, which are characterized by the expression of a single MHCII-restricted 
TCR that recognizes specifically the male H-Y antigen [109]. In Marilyn-Rag2-/- 
females, due to the absence of H-Y antigen, thymocytes are positively selected 
and differentiate in CD4+ SP thymocytes (Figure S11.A). However, in Marilyn-Rag2-
/- males, thymocytes are negatively selected at the DP stage (Figure S11.A), after 
TCR recognition of HY-MHCII complexes presented by the cortical epithelium 
[121]. Our preliminary results indicate that in the female thymi, the interactions 
between TEC and thymocytes during positive selection are sufficient to decrease 
the frequency of IL7hi/YFP+ TEC (Figure S11.B, middle panel; Figure S11.C, left 
graph), recapitulating the phenotype observed in age-matched 
immunocompetent mice. Remarkably in the male thymi, high-affinity TCR-
HY/MHC interactions between thymocytes and TECs during negative selection 
conspicuously accelerate the decay in IL7hi/YFP+ TECs (Figure S11.B, right panel; 
Figure S11.C, left graph). In agreement with previous findings, the frequency of 
CD80+ mTECs is increased in Marilyn-Rag2-/- males comparatively with females 
(Figure S11.B, middle and right panel), which is consistent with the idea that 
strong antigen-specific interactions with auto-reactive thymocytes are important 
to ensure the proper establishment of the medullary epithelium [104]. Taken 
together, our data suggest that the homeostasis of IL7hi/YFP+ TECs is controlled by 
the strength of TCR-mediated signals generated during thymocyte selection. 
In conclusion, this thesis defines a novel checkpoint governing the 
differentiation of the cortical thymic epithelium. By performing a fully 
comprehensive study of IL-7 reporter mice, we demonstrate that IL7hi/YFP+ TECs 
represent a determinant of cTEC lineage and provide evidence that their 
homeostasis is modulated by the strength of TCR-MHC interactions between 
thymocytes and TEC during thymocyte selection. Despite the substantial progress 
made, further studies are needed to understand the molecular basis behind the 
initial establishment and differentiation of TECs, with particular regard to cTECs. 
This knowledge will have important repercussions in the development of TEC 
rejuvenatory strategies particularly important in the context of acquired and 
congenital immunodeficiencies. 
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Figure S1 - Gating scheme of TECs by flow cytometry analysis. TECs are included within the CD45-/MHCII+/EpCAM+ fraction of the 
thymus. 
 
Figure S2 - IL7hi/YFP+ TECs are markedly augmented in adult and old Rag2-/- thymi. Dynamics of IL7hi/YFP+ TECs (gated on CD45-
/MHCII+/EpCAM+) were compared between immunocompetent (top panel) and Rag2-/- (bottom panel) IL-7 reporter mice at the indicated 
time points. Numbers indicate the percentage of gated cells. 
 
	  
Figure S3 - The decline in the proliferative status of TECs is independent of a normal programme of T cell development. Cell cycle 
analysis of purified TEC subsets were analysed by PI staining at different time points of thymic development. The frequency of cycling 
cells within YFPneg (gray) and IL7hi/YFP+ TECs (green) was calculated for A) immunocompetent mice and B) Rag2-/- mice. (*) indicates that the 
differences between groups are statistical significant (p<0.05).  
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Figure S4 - IL7hi/YFP+ TECs are unresponsive to RANK-derived signals independently of the stage of thymic development. E17 thymic 
lobes were left untreated (FTOC) and treated with deoxyguanosine (dGuo FTOC), in the presence or absence of agonistic antibody for 
RANK (αRANKL) A) TECs were analyzed for the expression of YFP (top panel) and BP1 and CD80 (middle and bottom panels) 
(representative experiment). The middle panel shows total TEC gate, whereas the bottom panel represents an overlay of YFPneg (gray) and 
Il7hi/YFP+ (green) TECs. B) Histogram representation of the YFP expression for the different conditions represented in A. C) Data represents 
the average of the fold difference in the Mean Fluorescence Intensity (MFI) of YFP (left). The MFI of the expression of YFP in Il7hi/YFP+ TECs 
from thymi treated with dGuo was set as 1. The percentage of Il7hi/YFP+ TECs and CD80+ TECs after FTOCs is represented on the middle and 
right graph, respectively. (*) indicates that the differences between groups are statistical significant (p<0.05).  
 
	  
Figure S5 - The cooperative effect between RANK and LTβR-derived signals does not affect the homeostasis of IL7hi/YFP+ TECs. E14 
thymic lobes were placed in FTOC treated with deoxyguanosine (dGuo FTOC), and stimulated with agonistic antibody for RANK (αRANK) 
and LTβR (αLTβR). A) TECs were analyzed for the expression of YFP (top panel) and BP1 and CD80 (middle and bottom panels) 
(representative experiment). The middle panel shows total TEC gate, whereas the bottom panel represents an overlay of YFPneg (gray) and 
Il7hi/YFP+ (green) TECs. B) Histogram representation of the YFP expression for the different conditions represented in A. C) Data represents 
the average of the fold difference in the Mean Fluorescence Intensity (MFI) of YFP (left). The MFI of the expression of YFP in Il7hi/YFP+ TECs 
from thymi treated with dGuo was set as 1. The percentage of Il7hi/YFP+ TECs and CD80+ TECs after FTOCs is represented on the middle and 
right graph, respectively. (*) indicates that the differences between groups are statistical significant (p<0.05).  
 
41.7 58.3 34.1 65.9 17.9 82.1 
0
20
40
60
80
0
5
10
15
20
0.0
0.5
1.0
+dGuo 
+αRANK +αRANK+ αLTβR 
* 
* 
0.12 
99.3 
17.3 
81.7 
2.19 
97.4 
0.14 
99.4 
9.85 
89.1 
2.5 
96.4 
B A 
C 
YFP 
%
 C
D
80
+  T
EC
s 
%
 IL
7h
i/Y
FP
+  T
EC
s 
 
+dGuo αRANK + αLTβR 
 
αRANK 
M
FI
 Y
FP
 
(fo
ld
 d
iff
er
en
ce
)  
+dGuo αRANK + αLTβR αRANK 
M
H
C
II 
YFP 
BP1 (cTEC) 
C
D
80
 (m
TE
C
) 
dGuo + αRANK 
B 
FTOC +dGuo 
+αRANK 
1.74 2.8 0 
9.35 6.16 
93 
0 
A 
C 
97.1 
97.1 97.1 
YFP 
%
 C
D
80
+  T
EC
s 
%
 IL
7h
i/Y
FP
+  T
EC
s 
 
+dGuo FTOC dGuo + αRANK 
* 
M
FI
 Y
FP
 
(fo
ld
 d
iff
er
en
ce
)  
+dGuo 
M
H
C
II 
YFP 
BP1 (cTEC) 
C
D
80
 (m
TE
C
) 
19.9 80.1 21 79 57.6 42.4 
99.9 90.2 
97.9 96.9 100 
FTOC 
Chapter VI | Supplemental Information 
	   65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6 - Anti-CD3ε  mAb treatment in Rag2-/- mice induces thymic expansion and promotes the differentiation of DN thymocytes 
into the DP stage. Rag2-/- neonatal mice were treated with anti-CD3ε and analyzed 5 and 12 days after treatment together with age-
matched (10-14 days old) immuno-competent mice. A) Macroscopic image of control and treated thymi. B) Thymic cellularity. C) 
CD4/CD8 profile in control, anti-CD3ε treated Rag2-/- and immunocompetent thymocytes and D) Numbers of different thymocyte 
populations isolated either from control and treated Rag2-/- mice. 
	  
Figure S7 - Molecular profile of the medullary thymic epithelium upon anti-CD3ε mAb treatment in Rag2-/- mice. YFPneg (gray) and 
Il7hi/YFP+ TECs (green) purified at the indicated time points were analyzed for the expression of Ctss (Cathepsin S), Tnfrsf11a (RANK) and 
Aire. Values were normalized to 18s or ß-actin. Il7hi/YFP+ TECs were set as 1, at each time point, and the fold difference in the relative 
mRNA expression was compared to YFPneg TECs.  
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Figure S8 - The emergence of mTECs in Rag2-/- treated mice does not occur due to a direct effect of anti-CD3ε mAb stimulation in 
the thymic epithelium. E14 thymic lobes were placed in dGuo-treated FTOC, in the presence or absence of anti-CD3ε mAb. TECs were 
analysed for the expression of BP1 and CD80. 
 
Figure S9 - Anti-CD3ε treatment does not affect the expression levels of thymocyte-derived RANKL and CD40L. Different thymocyte 
subsets from control, anti-CD3ε treated and immunocompetent mice were purified by cell sorting and analysed for the expression of 
Tnfsf11 (RANKL) and Cd40lg (CD40L). Values were normalized to ß-actin.	  
 
Figure S10 - Thymic microenvironment from 2 weeks old immunocompetent mice. Representative immunohistochemical analysis of 
thymic sections obtained from immunocompetent IL-7 reporter mice. Sections were stained with the following antibodies: YFP, green; 
CD8, red (left panel), YFP, green; CD205, red; MHCII, blue (middle panel), DAPI, blue; YFP, green; MTS10, red (right panel). 
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Figure S11 - The strength of TCR-MHC interactions during thymocyte selection modulates the homeostasis of IL7hi/YFP+ TECs. A) 
CD4/CD8 profile of the thymic hematopoietic fraction isolated from control Rag2-/-, female and male Marilyn Rag2-/- mice. B) TECs were 
analyzed for the expression of YFP (top panel) and BP1 and CD80 (middle and bottom panels). Middle panel (total TECs) and bottom 
panel (overlay of YFPneg (gray) and Il7hi/YFP+ (green) TECs. C) Fold difference in the Mean Fluorescence Intensity (MFI) of YFP expression 
(left), percentage of Il7hi/YFP+ (middle) and CD80+ (right) TECs. (*) indicates that the differences between groups are statistical significant 
(p<0.05). 
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